Rocket Pharmaceuticals Inc
General ticker "RCKT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.2B
Rocket Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -28.9%.
Estimated limits based on current volatility of 3.6%: low 11.11$, high 11.93$
Factors to consider:
- Current price 34.8% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [17.72$, 39.41$]
- 2024-12-30 to 2025-12-30 estimated range: [14.08$, 32.83$]
Financial Metrics affecting the RCKT estimates:
- Negative: Non-GAAP EPS, $ of -2.94 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -8.14 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: 0 < Interest expense per share, $ of 0.02
Short-term RCKT quotes
Long-term RCKT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $167.25MM | $224.34MM | $259.66MM |
| Operating Income | $-167.25MM | $-224.34MM | $-259.66MM |
| Non-Operating Income | $-1.82MM | $2.48MM | $14.06MM |
| Interest Expense | $5.89MM | $1.91MM | $1.88MM |
| R&D Expense | $125.48MM | $165.57MM | $186.34MM |
| Income(Loss) | $-169.07MM | $-221.86MM | $-245.59MM |
| Taxes | $0.52MM | $-2.48MM | $0.00MM |
| Profit(Loss) | $-169.59MM | $-219.38MM | $-245.59MM |
| Stockholders Equity | $454.72MM | $489.69MM | $492.57MM |
| Assets | $497.02MM | $551.81MM | $566.34MM |
| Operating Cash Flow | $-121.16MM | $-178.14MM | $-194.92MM |
| Capital expenditure | $7.71MM | $8.62MM | $16.47MM |
| Investing Cash Flow | $18.85MM | $-69.33MM | $-98.07MM |
| Financing Cash Flow | $37.68MM | $155.29MM | $208.40MM |
| Earnings Per Share* | $-2.68 | $-3.22 | $-2.92 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.